| Mutational landscape and significance across 12 major cancer types C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu, M Xie, Q Zhang, ... Nature 502 (7471), 333-339, 2013 | 4770 | 2013 |
| Genomic and Epigenomic Landscapes of Adult de novo acute myeloid leukemia New England Journal of Medicine 368 (22), 2059-2074, 2013 | 4765* | 2013 |
| Recurring mutations found by sequencing an acute myeloid leukemia genome ER Mardis, L Ding, DJ Dooling, DE Larson, MD McLellan, K Chen, ... New England Journal of Medicine 361 (11), 1058-1066, 2009 | 2694 | 2009 |
| Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing L Ding, TJ Ley, DE Larson, CA Miller, DC Koboldt, JS Welch, JK Ritchey, ... Nature 481 (7382), 506-510, 2012 | 2536 | 2012 |
| DNMT3A Mutations in Acute Myeloid Leukemia TJ Ley, L Ding, MJ Walter, MD McLellan, T Lamprecht, DE Larson, ... New England Journal of Medicine 363 (25), 2424-2433, 2010 | 2409 | 2010 |
| Age-related mutations associated with clonal hematopoietic expansion and malignancies M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ... Nature medicine 20 (12), 1472-1478, 2014 | 1947 | 2014 |
| The origin and evolution of mutations in acute myeloid leukemia JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ... Cell 150 (2), 264-278, 2012 | 1839 | 2012 |
| The genetic basis of early T-cell precursor acute lymphoblastic leukaemia J Zhang, L Ding, L Holmfeldt, G Wu, SL Heatley, D Payne-Turner, ... Nature 481 (7380), 157-163, 2012 | 1813 | 2012 |
| BreakDancer: an algorithm for high-resolution mapping of genomic structural variation K Chen, JW Wallis, MD McLellan, DE Larson, JM Kalicki, CS Pohl, ... Nature methods 6 (9), 677-681, 2009 | 1643 | 2009 |
| DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome TJ Ley, ER Mardis, L Ding, B Fulton, MD McLellan, K Chen, D Dooling, ... Nature 456 (7218), 66-72, 2008 | 1592 | 2008 |
| Lymphocyte-mediated cytotoxicity JH Russell, TJ Ley Annual review of immunology 20 (1), 323-370, 2002 | 1526 | 2002 |
| Human T regulatory cells can use the perforin pathway to cause autologous target cell death WJ Grossman, JW Verbsky, W Barchet, M Colonna, JP Atkinson, TJ Ley Immunity 21 (4), 589-601, 2004 | 1487 | 2004 |
| Genome remodelling in a basal-like breast cancer metastasis and xenograft LI Ding, MJ Ellis, S Li, DE Larson, K Chen, JW Wallis, CC Harris, ... Nature 464 (7291), 999-1005, 2010 | 1352 | 2010 |
| Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance X Cao, SF Cai, TA Fehniger, J Song, LI Collins, DR Piwnica-Worms, ... Immunity 27 (4), 635-646, 2007 | 1297 | 2007 |
| Whole-genome analysis informs breast cancer response to aromatase inhibition MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ... Nature 486 (7403), 353-360, 2012 | 1212 | 2012 |
| Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells JW Heusel, RL Wesselschmidt, S Shresta, JH Russell, TJ Ley Cell 76 (6), 977-987, 1994 | 1106 | 1994 |
| Clonal architecture of secondary acute myeloid leukemia MJ Walter, D Shen, L Ding, J Shao, DC Koboldt, K Chen, DE Larson, ... New England Journal of Medicine 366 (12), 1090-1098, 2012 | 980 | 2012 |
| Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ... Nature 518 (7540), 552-555, 2015 | 833 | 2015 |
| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 829 | 2016 |
| Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis A Belaaouaj, R McCarthy, M Baumann, Z Gao, TJ Ley, SN Abraham, ... Nature medicine 4 (5), 615-618, 1998 | 829 | 1998 |
